Emerson Chen
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 24
- Colorectal Cancer Treatments and Studies 12
- Colorectal Cancer Surgical Treatments 9
- Cancer Immunotherapy and Biomarkers 4
- Pancreatic and Hepatic Oncology Research 3
-
- Hepatitis C virus research 3
- Co-authors
- Vinay K. Prasad (10 shared papers)John P. Marquart (1 shared paper)Vikram M. Raghunathan (1 shared paper)Alyson Haslam (5 shared papers)Sunil Kumar Joshi (1 shared paper)Audrey A. Tran (1 shared paper)Charles D. Lopez (16 shared papers)Adel Kardosh (16 shared papers)
- Journals
- Annals of Surgical Oncology (4 papers)Cancers (4 papers)JAMA Internal Medicine (3 papers)The American Journal of Surgery (2 papers)Cancer Medicine (2 papers)
- Partner nations
- United StatesChinaSwitzerland
In The Last Decade
Emerson Chen
53 papers receiving 1.2k citations
Emerson Chen's Hit Papers
Peers
Comparison fields: 5 of 73
- Hepatology 125
- Oncology 294
- Statistics and Probability 149
- Cancer Research 125
- Pharmacology 63
Countries citing papers authored by Emerson Chen
This map shows the geographic impact of Emerson Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emerson Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emerson Chen more than expected).
Fields of papers citing papers by Emerson Chen
This network shows the impact of papers produced by Emerson Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emerson Chen. The network helps show where Emerson Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Emerson Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 261 | |
| 2 | Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study Hit paper breakdown → | 2023 | 190 |
| 3 | 2019 | 121 | |
| 4 | 2019 | 115 | |
| 5 | 2020 | 80 | |
| 6 | 2013 | 73 | |
| 7 | 2013 | 27 | |
| 8 | 2020 | 26 | |
| 9 | 2012 | 24 | |
| 10 | 2022 | 22 | |
| 11 | 2018 | 21 | |
| 12 | 2021 | 19 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 15 | |
| 15 | 2022 | 15 | |
| 16 | 2021 | 14 | |
| 17 | 2021 | 13 | |
| 18 | 2022 | 13 | |
| 19 | 2022 | 12 | |
| 20 | 2016 | 11 |
About Emerson Chen
Emerson Chen is a scholar working on Oncology, Hepatology, Statistics and Probability, Surgery and Pharmacology, having authored 55 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Colorectal Cancer Surgical Treatments (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Statistical Methods in Clinical Trials (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Economic and Financial Impacts of Cancer (3 papers), Hepatitis C virus research (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). The work is most often cited by research in Hepatology (125 citations), Oncology (294 citations), Statistics and Probability (149 citations), Cancer Research (125 citations) and Pharmacology (63 citations). Emerson Chen has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include Vinay K. Prasad, John P. Marquart, Vikram M. Raghunathan, Alyson Haslam, Sunil Kumar Joshi, Audrey A. Tran, Charles D. Lopez, Adel Kardosh, Amit G. Singal and Skye C. Mayo. Their work appears in journals such as Annals of Surgical Oncology, Cancers, JAMA Internal Medicine, The American Journal of Surgery and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.